Entering text into the input field will update the search result below

Medicines Company receives Cangrelor blow from FDA

Feb. 10, 2014 8:37 AM ETThe Medicines Company (MDCO) StockMDCOBy: Yigal Grayeff, SA News Editor
  • FDA staff have said that Medicines Company's (NASDAQ:MDCO) Cangrelor drug for preventing blood clots should not be approved, with the treatment needing another trial in order to correct flaws in earlier studies.
  • The FDA's recommendation comes ahead of a meeting of an advisory committee that is due to take place on Wednesday.
  • Shares are -13%. (PR)

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
MDCO--
The Medicines Company